Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-097135

Chief Executive Officer sold 2,536 shares at $1.97 ($4,993)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2022-09-01 Sale −2,536 $1.97 $4,993 3,316 D: show line 1 in the form
Open-market sales · 2,536 sh · avg $1.97 · $4,993
Loading xslF345X03/tm2224996-1_4seq1.xml…